Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Sounds good, Kieron. There is no rush to accumulate this small but fundamentally attractive asset. It gives us time to continue to observe its development with its new products while its vascular business continues to be the cash cow for them.